GLP-1 binds to a specific GLP-1 receptor, whose activation can promote the reduction of liver steatosis by improving insulin signaling pathways, hepatocyte lipotoxicity, and mitochondrial function [95,96]. The gene discussed is GLP1R; the disease is Hepatic steatosis.